ICFI vs MRTN

ICFI presents as a classic value trap; while the Piotroski F-Score of 4/9 indicates stable health and the current price sits below the Graham Number ($79.23), the fundamental growth trajectory is severely compromised. Revenue and earnings are contracting by double digits (-10.6% and -27.4% YoY, respectively), and the technical trend is completely bearish (0/100). Despite a low Forward P/E of 8.82, the disconnect between analyst price targets ($105.25) and the actual price action suggests a failure of the growth thesis.

Despite a strong Piotroski F-Score of 8/9 indicating excellent short-term financial health and a pristine balance sheet with zero debt, MRTN is fundamentally overvalued. The current price of $14.11 trades at a massive premium to both its Graham Number ($6.67) and Intrinsic Value ($1.47), while the company suffers from negative revenue (-8.80%) and earnings growth (-42.20%). Furthermore, the dividend is unsustainable with a payout ratio of 114.29%, suggesting the company is returning more capital than it generates.